AI Clinical Scribe Tool Risk Assessment
Six risks rated by likelihood and impact, with controls mapped to specific HIPAA rule sections.
- Classification
- Confidential
- Owner
- Security and Compliance
- Version
- 1.0
- Review cycle
- Annual
Purpose and Scope
This assessment evaluates the privacy and security risks introduced by ClinScribe AI, an ambient clinical documentation tool that records patient encounters and generates draft clinical notes. The tool processes protected health information (PHI) and integrates with the electronic health record.
Scope covers the audio capture pipeline, the third-party transcription service, the note generation model, and the EHR write-back integration. It does not cover general network infrastructure, which is assessed separately.
Rating Methodology
Each risk is scored on likelihood and impact using a three-point scale. The overall rating is the higher of the two dimensions, escalated one level when both are elevated.
| Rating | Definition | Response expectation |
|---|---|---|
| High | Likely occurrence or severe impact to PHI confidentiality | Remediate before production use |
| Medium | Possible occurrence with contained impact | Mitigate with compensating controls |
| Low | Unlikely occurrence with limited impact | Monitor and document acceptance |
Risk Register
| ID | Risk | Likelihood | Impact | Rating | Control | HIPAA |
|---|---|---|---|---|---|---|
| R-01 | Audio captured outside the encounter records bystander conversations | Medium | High | High | Push-to-talk activation and automatic silence trimming; staff training on capture boundaries | 164.312(b) |
| R-02 | Transcription vendor retains PHI beyond contracted period | Medium | High | High | Business Associate Agreement with 30-day deletion clause; annual attestation | 164.504(e) |
| R-03 | Generated note contains fabricated clinical detail not stated by clinician | Medium | Medium | Medium | Mandatory clinician review and sign-off before note is committed to the record | 164.312(c)(1) |
| R-04 | PHI transmitted to model endpoint without encryption in transit | Low | High | Medium | TLS 1.2 or higher enforced; certificate pinning on the mobile client | 164.312(e)(1) |
| R-05 | Unauthorized user accesses draft notes on a shared workstation | Medium | Medium | Medium | Automatic session lock after two minutes; unique user authentication | 164.312(a)(2)(iii) |
| R-06 | No audit trail linking a generated note to the source recording | Low | Medium | Low | Immutable audit log capturing recording ID, model version, and reviewer | 164.312(b) |
Recommendation
Two high risks (R-01, R-02) must be remediated before ClinScribe AI is approved for production. The remaining risks are acceptable with the listed controls in place. A follow-up review is scheduled 90 days after go-live to confirm control effectiveness.